Ionis Pharmaceuticals Inc

NASDAQ:IONS   3:59:58 PM EDT
37.56
-0.41 (-1.08%)
Products

Ionis Treatment For Angelman Syndrome Receives Orphan Drug And Rare Pediatric Disease Designations From U.S. FDA

Published: 06/13/2022 11:46 GMT
Ionis Pharmaceuticals Inc (IONS) - Ionis Treatment for Angelman Syndrome Receives Orphan Drug and Rare Pediatric Disease Designations From U.S. FDA.
Ionis Treatment for Angelman Syndrome Receives Orphan Drug and Rare Pediatric Disease Designations From U.S. FDA.